The Latest Breaking News from Health Canada

For those unaware, Canada provides a legal way for patients presenting unresolved mental health issues to receive psychedelic-assisted treatment.

The Canadian government has given its approval to AMX0035, a new drug from Cambridge, Massachusetts-based Amylyx Pharmaceuticals Inc.

Numinus Wellness Inc (OTCQB: NUMIF) has been approved to use psilocybin-assisted therapy through Health Canada’s Special Access Program (SAP), marking the first instance in which Numinus will provide this treatment outside of a clinical trial.

Red Light Holland (OTCPK:TRUFF) has announced the successful export of psilocybin truffles to its partner in Canada, CCrest Laboratories, through a permit given by Health Canada.

Val Demings and Mark Takano tell The Independent the US should also ‘follow science’

The Blinc Group Names New COO The Blinc Group, Inc., a regulatory-focused designer, and provider of premium customized vaporizer technologies, has tapped cannabis industry veteran Pete Sahani to serve as its new chief operating officer.

HEXO Corp (NASDAQ: HEXO) (TSX:HEXO) announced that Charlie Bowman has been appointed the company’s acting president and CEO.

Health Canada has lifted restrictions on gay men donating blood, a move Prime Minister Justin Trudeau says is “good news for all Canadians” but took too long

Yesterday, the broad market indices closed in negative territory on interest-rate-increase concerns. Goldman Sachs has predicted that the S&P might tumble to 3,600 this year if recessionary pressure persists. Non-cyclical stocks usually perform well during economic downturns. So, we believe Cardinal Health (CAH), Brookfield Infrastructure Corp. (BIPC), Smith & Nephew…